Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Susan P, Buchbinder"'
Autor:
Yunda Huang, Yuanyuan Zhang, Kelly E. Seaton, Stephen De Rosa, Jack Heptinstall, Lindsay N. Carpp, April Kaur Randhawa, Lyle R. McKinnon, Paul McLaren, Edna Viegas, Glenda E. Gray, Gavin Churchyard, Susan P. Buchbinder, Srilatha Edupuganti, Linda-Gail Bekker, Michael C. Keefer, Mina C. Hosseinipour, Paul A. Goepfert, Kristen W. Cohen, Brian D. Williamson, M. Juliana McElrath, Georgia D. Tomaras, Juilee Thakar, James J. Kobie
Publikováno v:
EBioMedicine, Vol 84, Iss , Pp 104271- (2022)
Summary: Background: The identification of baseline host determinants that associate with robust HIV-1 vaccine-induced immune responses could aid HIV-1 vaccine development. We aimed to assess both the collective and relative performance of baseline c
Externí odkaz:
https://doaj.org/article/fadb3c4955a04c03b07eef2fa43a9e8d
Autor:
Anne F. Luetkemeyer, Deborah Donnell, Julia C. Dombrowski, Stephanie Cohen, Cole Grabow, Clare E. Brown, Cheryl Malinski, Rodney Perkins, Melody Nasser, Carolina Lopez, Eric Vittinghoff, Susan P. Buchbinder, Hyman Scott, Edwin D. Charlebois, Diane V. Havlir, Olusegun O. Soge, Connie Celum
Publikováno v:
New England Journal of Medicine. 388:1296-1306
Autor:
Susan P. Buchbinder, Aaron J. Siegler, Kenneth Coleman, Eric Vittinghoff, Gretchen Wilde, Annie Lockard, Hyman Scott, Peter L. Anderson, Nicole Laborde, Ariane van der Straten, Richard H. Christie, Michelle Marlborough, Albert Y. Liu
Publikováno v:
AIDS and Behavior. 27:719-732
Measurement of adherence to oral pre-exposure prophylaxis (PrEP) in real-time has been challenging. We developed DOT Diary, a smartphone application that combines automated directly observed therapy with a PrEP adherence visualization toolkit, and te
Autor:
Holly Janes, Marshall D Brown, David V Glidden, Kenneth H Mayer, Susan P Buchbinder, Vanessa M McMahan, Mauro Schechter, Juan Guanira, Martin Casapia
Publikováno v:
PLoS ONE, Vol 14, Iss 9, p e0222183 (2019)
IntroductionDeveloping guidelines to inform the use of antiretroviral pre-exposure prophylaxis (PrEP) for HIV prevention in resource-limited settings must necessarily be informed by considering the resources and infrastructure needed for PrEP deliver
Externí odkaz:
https://doaj.org/article/8e335fda570043e692ab1ed0cc602769
Autor:
Matthew A Spinelli, Noelle Le Tourneau, David V Glidden, Ling Hsu, Matthew D Hickey, Elizabeth Imbert, Mireya Arreguin, Jennifer P Jain, Jon J Oskarsson, Susan P Buchbinder, Mallory O Johnson, Diane Havlir, Katerina A Christopoulos, Monica Gandhi
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol 75, iss 1
Background After coronavirus disease 2019 (COVID-19) shelter-in-place (SIP) orders, viral suppression (VS) rates initially decreased within a safety-net human immunodeficiency virus (HIV) clinic in San Francisco, particularly among people living with
Autor:
Rajesh T. Gandhi, Roger Bedimo, Jennifer F. Hoy, Raphael J. Landovitz, Davey M. Smith, Ellen F. Eaton, Clara Lehmann, Sandra A. Springer, Paul E. Sax, Melanie A. Thompson, Constance A. Benson, Susan P. Buchbinder, Carlos del Rio, Joseph J. Eron, Huldrych F. Günthard, Jean-Michel Molina, Donna M. Jacobsen, Michael S. Saag
Publikováno v:
JAMA. 329(1)
ImportanceRecent advances in treatment and prevention of HIV warrant updated recommendations to guide optimal practice.ObjectiveBased on a critical evaluation of new data, to provide clinicians with recommendations on use of antiretroviral drugs for
Autor:
Timothy J Henrich, Hiroyu Hatano, Oliver Bacon, Louise E Hogan, Rachel Rutishauser, Alison Hill, Mary F Kearney, Elizabeth M Anderson, Susan P Buchbinder, Stephanie E Cohen, Mohamed Abdel-Mohsen, Christopher W Pohlmeyer, Remi Fromentin, Rebecca Hoh, Albert Y Liu, Joseph M McCune, Jonathan Spindler, Kelly Metcalf-Pate, Kristen S Hobbs, Cassandra Thanh, Erica A Gibson, Daniel R Kuritzkes, Robert F Siliciano, Richard W Price, Douglas D Richman, Nicolas Chomont, Janet D Siliciano, John W Mellors, Steven A Yukl, Joel N Blankson, Teri Liegler, Steven G Deeks
Publikováno v:
PLoS Medicine, Vol 14, Iss 11, p e1002417 (2017)
BackgroundIt is unknown if extremely early initiation of antiretroviral therapy (ART) may lead to long-term ART-free HIV remission or cure. As a result, we studied 2 individuals recruited from a pre-exposure prophylaxis (PrEP) program who started pro
Externí odkaz:
https://doaj.org/article/7146700700d742c7a0dd1a56e69b9226
Autor:
Susan P Buchbinder, Nicole A Grunenberg, Brittany J Sanchez, Kelly E Seaton, Guido Ferrari, M Anthony Moody, Nicole Frahm, David C Montefiori, Christine M Hay, Paul A Goepfert, Lindsey R Baden, Harriet L Robinson, Xuesong Yu, Peter B Gilbert, M Juliana McElrath, Yunda Huang, Georgia D Tomaras, HIV Vaccine Trials Network (HVTN) 094 Study Group
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0179597 (2017)
BACKGROUNDA phase 1 trial of a clade B HIV vaccine in HIV-uninfected adults evaluated the safety and immunogenicity of a DNA prime co-expressing GM-CSF (Dg) followed by different numbers and intervals of modified vaccinia Ankara Boosts (M). Both vacc
Externí odkaz:
https://doaj.org/article/300820dc06284fec8a11c5a6cc8671e2
Publikováno v:
Open forum infectious diseases, vol 9, iss 7
Background In 2010–2014, the San Francisco Department of Public Health (SFDPH) established programs to rapidly link people with human immunodeficiency virus (PWH) to care and offer antiretroviral therapy (ART) at human immunodeficiency virus (HIV)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d38c6530755afd5966dcd6b275f2524f
https://escholarship.org/uc/item/251399rj
https://escholarship.org/uc/item/251399rj
Autor:
Matthew A. Spinelli, Lillian B. Brown, David V. Glidden, Kyle Hunter, Patrick Martin-Tuite, James Zheng, Curtis Sera, Diane Havlir, Susan P. Buchbinder, Monica Gandhi
Publikováno v:
AIDS (London, England), vol 35, iss 15
AIDS
AIDS
To assess SARS-CoV-2 outcomes, we matched a municipal COVID-19 registry and clinic rosters from a municipal primary care network containing a large HIV clinic and assessed clinical outcomes by HIV status. The risk of severe COVID-19 was higher among
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1d4b867b8e56fd73fe10bd79048bfde
https://escholarship.org/uc/item/3qw2k22b
https://escholarship.org/uc/item/3qw2k22b